Stock Taper
SCREENER COMPARE ANY 2 STOCKS
BIO
BIO-RAD LABORATORIES, INC.
NYSE
$380.03
▲ UP 0.95% (3.57)

KEY STATISTICS

Market Cap$10.23 B
52w High$385.92
52w Low$236.73
Dividend Yield—
Frequency—
P/E40.95
Volume302.71K
Shares Out.26.92M

COMPANY

LEADERSHIP

Norman D. Schwartz
CHIEF EXECUTIVE
Norman D. Schwartz

COMPENSATION 2026

Salary$1,089,877
Stock Awards$4,856,574
Incentive Plan Pay$562,088
All Other Comp.$28,327
Total$7,995,841

ABOUT

SECTOR
Healthcare
WENT PUBLIC
February 27, 1980
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
7,450

PRICE TARGET

Target High$390.00
Target Low$310.00
Target Median$350.00
Target Consensus$350.00

UPCOMING EARNINGS

DateOct 29, 2026
DayThursday
Rev. Est.$650.65M
OCT
29
THU

SPLIT RECORD

DATETYPERATIO
2002-03-08Forward2:1
1996-06-03Forward3:2
1986-06-11Forward3:2
1985-08-01Forward3:2
1980-03-18Forward2:1

PRICE

$380.03 ▲ UP 0.95% (+$3.57)
OVERLAYS
$376$380$3849:30 AM10:35 AM11:40 AM12:44 PM1:49 PM2:54 PM3:59 PM380.03

About Bio-Rad Laboratories, Inc.

https://www.bio-rad.com ↗

Bio-Rad Laboratories, Inc. develops and distributes life science research and clinical diagnostic products globally, serving research, biopharmaceutical, food safety, and clinical laboratories through its Life Science and Clinical Diagnostics segm...

INDUSTRY

Medical - Devices

A PRODUCT BIO-RAD LABORATORIES, INC. IS KNOWN FOR

QX700 Droplet Digital PCR System
QX700 Droplet Digital PCR System

The QX700 is a high-throughput, seven-color multiplexing Droplet Digital PCR system capable of processing over 700 samples daily, serving academic, gene therapy, and biopharma applications with advanced genetic analysis.

COMPETITORS

COMPETITOR
A COMPARE
DHR COMPARE
ILMN COMPARE
QGEN COMPARE
TMO COMPARE

Revenue by Products

IconPRODUCTQ3-2025Q4-2025Q1-2026Q2-2026
Clinical Diagnostics$391.2M $425.3M ▲$363.6M ▼$399M ▲
Life Science$261.8M $267.9M ▲$228.5M ▼$252M ▲

Revenue by Geography

MapREGIONQ3-2025Q4-2025Q1-2026Q2-2026
UNITED STATES$270M $244.1M ▼$229.8M ▼$255.5M ▲
Europe$222.2M $242.6M ▲$206.8M ▼$229.2M ▲
Asia Pacific$121M $161.8M ▲$110.4M ▼$121.8M ▲
Americas$39.8M $44.7M ▲$45.1M ▲$44.5M ▼

ETFS HOLDING THIS STOCK

ETFS HOLDING
240
LISTED HERE
26
RANKED BY POSITION SIZE
XMC.TO
0.19% · 624.0K
VTS.AX
0.01% · 586.7K
MDY
0.19% · 132.0K
DFSV
0.54% · 119.4K
FEGE
1.20% · 77.7K
FNDA
0.27% · 66.2K
USVM
0.38% · 17.7K
FXH
0.51% · 15.8K
JHMM
0.08% · 15.6K
FSMD
0.18% · 14.8K
AUSF
0.60% · 14.6K
XMLH.DE
1.55% · 12.9K
BBMC
0.14% · 8.2K
PRF
0.03% · 7.1K
SILX
2.29% · 6.7K
AVUS
0.01% · 4.5K
EZM
0.10% · 3.7K
HTEC
1.57% · 3.2K
BKMC
0.17% · 2.9K
AFTY
0.23% · 2.8K
TPSC
0.25% · 2.5K
ETHO
0.40% · 2.1K
SF
SFGV
0.06% · 1.9K
OP
OPTZ
0.21% · 1.5K
PTL
0.06% · 1.4K
ZMID.TO
0.19% · 1.3K

INSTITUTIONAL OWNERSHIP

SHARES OWNED
50.47%
HOLDERS
668
TOP 12 OF 668 · RANKED BY POSITION SIZE
First Eagle Investment Management, LLC
2.6M sh · $765.21M
Vanguard Group Inc
1.8M sh · $502.89M
Blackrock, Inc.
1.7M sh · $498.82M
Blackrock Inc.
1.6M sh · $423.48M
Dimensional Fund Advisors LP
1.1M sh · $303.64M
Blackrock Fund Advisors
873.4K sh · $159.2M
Veritas Asset Management Llp
844.0K sh · $236.66M
Ariel Investments, LLC
816.8K sh · $239.81M
Blackrock Institutional Trust Company, N.A.
636.9K sh · $116.09M
Earnest Partners LLC
609.3K sh · $170.84M
State Street Corp
571.8K sh · $167.88M
Capital Research Global Investors
494.5K sh · $149.82M

RATINGS SNAPSHOT

Overall rating: B+

DCFROEROAD/EP/EP/B
Discounted Cash Flow3
Return On Equity3
Return On Assets4
Debt To Equity3
Price To Earnings1
Price To Book4
Overall Score3

TRADES BY CONGRESS

HOUSE TRADES
Ro Khanna
Ro Khanna
Sale
2023-11-03
 Lois Frankel
Lois Frankel
Sale
2023-09-08
 Susie Lee
Susie Lee
Sale (Full)
2022-11-30
SENATE TRADES
Tommy Tuberville
Tommy Tuberville
Sale (Full)
2022-03-30

INSIDER TRADES

★
OFFICER: EVP, PRESIDENT, CDG
ENGELHARDT EVA ANETTE
Purchase · 246 shares
2026-07-25
★
OFFICER: EVP, PRESIDENT, CDG
ENGELHARDT EVA ANETTE
Sale · 89 shares
2026-07-25
★
OFFICER: EVP, PRESIDENT, CDG
ENGELHARDT EVA ANETTE
Sale · 246 shares
2026-07-25
★
OFFICER: EVP, PRESIDENT, CDG
ENGELHARDT EVA ANETTE
Sale · 550 shares
2026-05-11

MOST RECENT ANALYST GRADES

GRADE SUMMARY
OUTPERFORM 1
NEUTRAL 1
EQUAL WEIGHT 1
3 GRADES IN THE LAST 12 MONTHS
RBC Capital OUTPERFORM Citigroup NEUTRAL Wells Fargo EQUAL WEIGHT

SECTORS PEERS

PEERPRICE
CRL$295.19COMPARE
PEN$325.18COMPARE
GMED$86.91COMPARE
ALGN$162.55COMPARE
DVA$173.82COMPARE
HSIC$88.50COMPARE
HQY$105.41COMPARE
ATR$134.80COMPARE